OncoImmune
Rockville
About OncoImmune
OncoImmune is a clinical-stage biopharmaceutical company that engages in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease. It has completed a Phase II clinical trial of CD24Fc for the prophylactic treatment of acute Graft versus Host Disease for leukemia patients undergoing hematopoietic stem cell transplantation and is poised to launch a pivotal trial for the indication. Oncolmmune was founded in 2000 and is based in Rockville, Maryland.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Estimated revenue: $10M+
- Total funding: $74.0M
- Funding stage: M&A
- Last round: Series B (Sep 2020)
- Website: merck.com
- Phone: (301)557-9119
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/oncoimmune-162232 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.